Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • [Letter to the Editor] Incorre...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
[Letter to the Editor] Incorrect assignment of affected nucleotides in footprinting/probing experiments

[Letter to the Editor] Incorrect assignment of affected nucleotides in footprinting/probing experiments

Bibliographic Details
Main Authors: Sergey Belikov, Fredrik Lackmann, Lars Wieslander
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:BioTechniques
Subjects:
primer extension
Sanger sequencing
dITP
Online Access:https://www.future-science.com/doi/10.2144/000114585
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.future-science.com/doi/10.2144/000114585

Similar Items

  • Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping
    by: Baowei Li, et al.
    Published: (2021-11-01)
  • Newly Diagnosed Primary Immune Thrombocytopenia in Children: Which Guideline to Adhere?
    by: Cipta Mahendra
    Published: (2021-08-01)
  • Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
    by: Gian Marco Podda, et al.
    Published: (2022-01-01)
  • Linker 2 of the eukaryotic pre-ribosomal processing factor Mrd1p is an essential interdomain functionally coupled to upstream RNA Binding Domain 2 (RBD2).
    by: Fredrik Lackmann, et al.
    Published: (2017-01-01)
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
    by: Monica Carpenedo, et al.
    Published: (2023-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs